Cargando…

Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α

Mutant forms of p53 protein often possess protumorigenic functions, conferring increased survival and migration to tumor cells via their “gain-of-function” activity. Whether and how a common polymorphism in TP53 at amino acid 72 (Pro72Arg; referred to here as P72 and R72) impacts this gain of functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu, Subhasree, Gnanapradeepan, Keerthana, Barnoud, Thibaut, Kung, Che-Pei, Tavecchio, Michele, Scott, Jeremy, Watters, Andrea, Chen, Qing, Kossenkov, Andrew V., Murphy, Maureen E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859965/ https://www.ncbi.nlm.nih.gov/pubmed/29463573 http://dx.doi.org/10.1101/gad.309062.117

Ejemplares similares

The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
por: Gnanapradeepan, Keerthana, et al.
Publicado: (2018)

Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser
por: Gnanapradeepan, Keerthana, et al.
Publicado: (2020)

African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin
por: Singh, Kumar Sachin, et al.
Publicado: (2020)

Author Correction: African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin
por: Singh, Kumar Sachin, et al.
Publicado: (2020)

Editorial: Double-edged swords: Important factors connecting metabolic disorders and cancer development – from basic research to translational applications
por: Kung, Che-Pei, et al.
Publicado: (2023)

Shifting the paradigms for tumor suppression: lessons from the p53 field
por: Barnoud, Thibaut, et al.
Publicado: (2021)

Common genetic variants in the TP53 pathway and their impact on cancer
por: Barnoud, Thibaut, et al.
Publicado: (2019)

Tumor cells containing the African-Centric S47 variant of TP53 show increased Warburg metabolism
por: Barnoud, Thibaut, et al.
Publicado: (2019)

PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis
por: Gnanapradeepan, Keerthana, et al.
Publicado: (2022)

Common activities and predictive gene signature identified for genetic hypomorphs of TP53
por: Leung, Jessica C., et al.
Publicado: (2023)

An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
por: Jennis, Matthew, et al.
Publicado: (2016)

Mutant p53 regulates Survivin to foster lung metastasis
por: Tang, Qiaosi, et al.
Publicado: (2021)

HSP70 Inhibition Blocks Adaptive Resistance and Synergizes with MEK Inhibition for the Treatment of NRAS-Mutant Melanoma
por: Parris, Joshua L.D., et al.
Publicado: (2021)

Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?
por: Duffy, Michael J., et al.
Publicado: (2022)

Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis
por: Gravel, Simon-Pierre
Publicado: (2018)

Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O(2ˉ)· production in cancer cells
por: Cordani, Marco, et al.
Publicado: (2018)

Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the Mouse
por: Piccinin, Elena, et al.
Publicado: (2019)

NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2
por: Donninger, Howard, et al.
Publicado: (2015)

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis
por: LeBleu, Valerie S., et al.
Publicado: (2014)

The metabolic co-regulator PGC1α suppresses prostate cancer metastasis
por: Torrano, Veronica, et al.
Publicado: (2016)

An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression
por: Indeglia, Alexandra, et al.
Publicado: (2023)

The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition
por: Stieg, David C., et al.
Publicado: (2023)

Editorial: Double-Edged Swords: Genetic Factors That Influence the Pathogenesis of Both Metabolic Disease and Cancer
por: Kung, Che-Pei, et al.
Publicado: (2019)

PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition
por: Oh, Taek-In, et al.
Publicado: (2021)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

Roles of Oxidative Stress, Apoptosis, PGC-1α and Mitochondrial Biogenesis in Cerebral Ischemia
por: Chen, Shang-Der, et al.
Publicado: (2011)

SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis
por: Li, Yuming, et al.
Publicado: (2016)

Mitochondrial Dysfunction in Huntington’s Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors
por: Intihar, Taylor A., et al.
Publicado: (2019)

p53/PGC-1α-mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis
por: Li, Jiuling, et al.
Publicado: (2020)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

A map of the PGC-1α- and NT-PGC-1α-regulated transcriptional network in brown adipose tissue
por: Chang, Ji Suk, et al.
Publicado: (2018)

Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function
por: Leu, Julia I-Ju, et al.
Publicado: (2017)

It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
por: Kung, Che-Pei, et al.
Publicado: (2022)

Pit PGC
por: CERN PhotoLab
Publicado: (1973)

PGC1α: Friend or Foe in Cancer?
por: Mastropasqua, Francesca, et al.
Publicado: (2018)

Telomeric injury by KML001 in human T cells induces mitochondrial dysfunction through the p53-PGC-1α pathway
por: Schank, Madison, et al.
Publicado: (2020)

Transcriptional Activity of PGC-1α and NT-PGC-1α Is Differentially Regulated by Twist-1 in Brown Fat Metabolism
por: Jun, Hee-Jin, et al.
Publicado: (2012)

Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease
por: Che, Hong Van B, et al.
Publicado: (2011)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Gluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathway
por: Jhuang, Hong-Jhih, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_65guvjafubuia2vutokf369vlb